Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial

We studied effectiveness of the AS04‐adjuvanted HPV‐16/18 (AS04‐HPV‐16/18) vaccine against human papillomavirus (HPV) oropharyngeal infections associated with the increase of head/neck cancers in western countries. All 38,631 resident adolescents from 1994 to 1995 birth cohorts of 33 Finnish communi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehtinen, Matti, Apter, Dan, Eriksson, Tiina, Harjula, Katja, Hokkanen, Mari, Lehtinen, Tuomas, Natunen, Kari, Damaso, Silvia, Soila, Maaria, Bi, Dan, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318585/
https://www.ncbi.nlm.nih.gov/pubmed/31736068
http://dx.doi.org/10.1002/ijc.32791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318585/
https://www.ncbi.nlm.nih.gov/pubmed/31736068
http://dx.doi.org/10.1002/ijc.32791

Ejemplares similares